Editorial Board

@davidvanduin

Current Positions and Research Interests

Dr van Duin is a Professor of Medicine and the founding Director of the Immunocompromised Host Infectious Diseases Program in the Infectious Diseases Division at the University of North Carolina. His research interests are infections caused by multidrug-resistant Gram-negative bacteria, and infections in immunocompromised patients including burn patients. He has a particular interest in translational research in carbapenemase-producing Enterobacteriaceae.

Declaration of Interests

Dr van Duin has received research support from the National Institutes of Health. He has served on Advisory Boards for Allergan, Achaogen, Qpex, Shionogi, Tetraphase, Sanofi-Pasteur, T2 Biosystems, NeuMedicine, Roche, MedImmune, Astellas and Merck.

@bhogal_pathogen

Current Positions and Research Interests

Rashmeet Bhogal is an Assistant Professor in Clinical Pharmacy at the University of Birmingham with a keen interest in the impact of spurious penicillin allergy labels on antimicrobial stewardship and antimicrobial resistance. As a previous specialist senior antimicrobial pharmacist prescriber, she has led on antimicrobial reduction within specialist prescribing as well as independently conducting antimicrobial stewardship across medicine, surgery and critical care. She is Lead Research Pharmacist for an NIHR-funded study for de-labelling spurious penicillin allergies by a non-allergy specialist: A multi-centre Study to Investigate a Protocol-Driven Multidisciplinary Service Model to Tackle ‘Spurious Penicillin Allergy’ in Secondary Care (SPACE study; NIHR129069), at the University Hospitals of Birmingham NHS Foundation Trust, Oxford University Hospitals NHS Trust and Leeds Teaching Hospitals NHS Trust. She is also undertaking a PhD examining wider topics around antibiotic allergies.

Her main research interests include understanding the global impact of spurious antibiotic allergy labels on antimicrobial stewardship and resistance, tackling spurious antibiotic and multiple antibiotic allergy labels in high-, middle- and low-income countries; and understanding the attitudes and behaviours of patients and healthcare professionals for de-labelling spurious antibiotic allergy labels, as well the implications of these across the local integrated care systems, which involves bringing together providers and commissioners of NHS services to collectively plan health and care services to meet the needs of the local population.

Declaration of Interests

Rashmeet Bhogal has received funding or honoraria for conference attendance, advisory boards, lectures, and training from Pfizer and Menarini. The SPACE study funding grant is from the National Institute for Health and Care Research.

@MSatlin

Current Positions and Research Interests

Dr. Satlin is an Associate Professor of Medicine and Clinical Director of the Transplantation-Oncology Infectious Diseases Program at Weill Cornell Medicine. He is also Member of the Clinical and Laboratory Standards Institute’s Subcommittee on Antimicrobial Susceptibility Testing and Co-Chair of its Breakpoint Working Group. His research interests include the epidemiology and treatment of infections caused by multidrug-resistant (MDR) Gram-negative bacteria, particularly in immunocompromised hosts, and the development and implementation of novel diagnostic tests to rapidly diagnose infections caused by these bacteria.

Declaration of Interests

Dr. Satlin has received research support from the National Institutes of Health, Allergan, Merck, Affinity Biosensors, and BioFire Diagnostics. He has also served on Advisory Boards for Shionogi and Achaogen.

@inspired2leadQH

Current Positions and Research Interests

Dr Dena van den Bergh is an honorary lecturer: Division of Infectious Diseases and HIV Medicine, Department of Medicine, Groote Schuur Hospital, University of Cape Town, Cape Town, South Africa. She also works independently in her own business in the field of health systems improvement. Her research interests include design and implementation of large scale change in healthcare including antimicrobial stewardship and infection prevention strategies across different healthcare settings, quality and systems improvement and change leadership in health systems improvement.

Declaration of Interests

None to declare.

Current Positions and Research Interests
Fergus Allerton is a European specialist in small animal internal medicine working at Willows Veterinary Centre and Referral Service. He is current chairman of the Small Animal Medicine Society. His main research interests relate to the development of antimicrobial stewardship initiatives among companion animal veterinarians.

Declaration of Interests
Fergus has received honoraria for speaking at symposia organized by Hills Pet Nutrition and BOVA Veterinary Specials and travel support to attend a conference from Boehringer Ingelheim.

@PK_asempa_PD

Current Positions and Research Interests

Dr Asempa is an Associate Director of the Center for Anti-infective Research and Development at Hartford Hospital. His research interests include pharmacokinetic/pharmacodynamic assessments of investigational and approved antibiotics using preclinical (murine models) and clinical models (healthy volunteer and Phase I-IV studies). He has interests in epidemiology of antimicrobial resistant determinants as well as improving patient outcomes through antimicrobial stewardship.

Declaration of Interests

Tomefa has received funding or honoraria for lectures and research from the United States Food and Drug Administration and a number of pharmaceutical companies including Paratek, Shionogi, Spero and Venatorx.

Current Positions and Research Interests

Sulagna Basu is a Scientist at the ICMR-National Institute of Cholera and Enteric Diseases, Kolkata, India and leads active research in antibiotic resistance in Gram-negative bacteria causing neonatal sepsis. Studies from her laboratory focus on various aspects of cephalosporin, carbapenem and colistin resistance in highly antibiotic-resistant Acinetobacter baumannii, Klebsiella pneumoniae and Escherichia coli. She is also as a member of the WHO Technical Advisory Group on Vaccines and Antimicrobial Resistance.

Declaration of Interests

Research by Dr Sulagna Basu is mainly supported by funding agencies of India Government.

@castrocloud

Current Positions and Research Interests

Dr Enrique Castro-Sánchez works as Lead Academic Research Nurse in the theme "Innovations in behaviour change, technology and patient safety to improve infection prevention and antimicrobial use” at the National Institute for Health Research Health Protection Research Unit in Healthcare Associated Infection and Antimicrobial Resistance at Imperial College London. He is also an Honorary Consultant Nurse in Communication and Patient Engagement at Imperial College Healthcare NHS Trust, and was recently appointed an NIHR 70@70 Senior Nurse Research Leader at the NIHR Academy. Enrique’s research interests include health literacy in infectious diseases and healthcare-associated infections; impact of health inequalities on infectious diseases; policy influence on management of infectious diseases; and implementation and evaluation of novel workforce roles. In addition to JAC-AMR, Enrique serves as Academic Editor at PLOS One journal, and Editorial Board Member for the ‘Infectious Disease Epidemiology’ section of BMC Public Health.

Declaration of Interests

Research by Dr Castro-Sánchez is mainly funded by the UK government and national agencies, and he has no current involvement with industry, but in the past he has received honoraria for consulting from Pfizer. He is member of BSAC (Council), Society of Spanish Researchers in the UK, European Society of Clinical Microbiology and Infectious Diseases, European Academy of Nursing Science, Joanna Briggs Institute Infection Control Expert Reference Group.

Current Positions and Research Interests

Dr Claeys is faculty at the University of Maryland School of Pharmacy and serves as the Co-Chair for the University of Maryland Medical System Sepsis Program Rapid Diagnostics Subcommittee. She has recently completed a PhD in Epidemiology at the University of Maryland School of Medicine, focusing on diagnostic stewardship. She is a Fellow of the Center for Innovation in Diagnosis at the University of Maryland School of Medicine and a Scholar in Diagnostic Excellence through the National Academy of Medicine. Her research interests include the intersection of antimicrobial and diagnostic stewardship, particularly focusing on principles of implementation science to improve antimicrobial use and diagnostic error.

Declaration of Interests

Dr Claeys served as a subject matter expert and advisory board member for bioMérieux and has received research support from QLinea Diagnostics.

Current Positions and Research Interests

Dr Patrick Harris is an Infectious Disease Physician and Clinical Microbiologist, based at the Royal Brisbane and Women’s Hospital and the Herston Infectious Diseases Institute in Brisbane, Australia. He is also a National Health and Medical Research Council (NHMRC) Emerging Leadership Fellow and Group Leader at The University of Queensland Centre for Clinical Research (UQCCR). He holds specialist accreditation in both infectious disease and clinical microbiology, and has worked in the UK, Malawi, Singapore and Australia. His research has a focus on antibiotic-resistant bacteria and the use of randomized trials to define optimal management for MDR Gram-negative pathogens. He was lead author for the influential MERINO trial, and has led the Queensland Genomics infection programme, aiming to introduce the routine application of pathogen genomics in clinical microbiology.

Declaration of Interests

Dr Harris has received research grants from Gilead and speaker’s fees from Pfizer, OpGen, Gilead and BioMerieux (paid to the University of Queensland) and served on advisory boards for OpGen, MSD/Merck and Sandoz.

@EB_Hirsch

Current Positions and Research Interests

Dr Hirsch is a tenured Associate Professor in the Department of Experimental and Clinical Pharmacology at the University of Minnesota College of Pharmacy. Her translational research programme focuses on the detection and treatment of MDR Gram-negative infections, with the overall goal of improving the use of antimicrobials for patients with resistant bacterial infections. Other specific research interests include susceptibility testing methods and urinary tract infections. Dr Hirsch has served in various roles of the Clinical and Laboratory Standards Institute (CLSI) Subcommittee on Antimicrobial Susceptibility Testing since 2017 and is a member of the ongoing IDSA 2019 update of the urinary tract infection guidelines expert panel.

Declaration of Interests

Dr Hirsch has received research funding from Merck and advisory board honoraria from GSK, Melinta, MeMed and Merck.

Current Positions and Research Interests

Dr Bernadette Jakeman is a licensed prescribing pharmacist clinician and Associate Clinical Professor at the University of New Mexico (UNM) College of Pharmacy. She leads an HIV Complex Care Clinic at the UNM Truman Health Services clinic and serves as the pharmacist clinician on the Adult Infectious Diseases Consult Service at UNM Hospital. Dr Jakeman’s primary research focuses on medication use in people with HIV. She also currently serves as a panel member of the NIH/CDC/HIVMA/IDSA Guidelines for HIV Opportunistic Infections in Adults and Adolescents with HIV.

Declaration of Interests

Dr Jakeman has served as a principal investigator for a Merck Investigator Initiated Research Project that was awarded through the University of New Mexico (funding was completed 31 August 2024). In addition, Dr Jakeman serves as a clinical consultant for Wolters-Kluwer (Lexidrug).

Current Positions and Research Interests

Dr Diamantis Kofteridis is an Associate Professor of Internal Medicine and Infectious diseases at the University of Crete, Greece. Currently as Associate Professor at the University of Crete, he is an Infectious Diseases Consultant and Attending physician in the Department of Internal Medicine of the University Hospital of Heraklion. His main medical interests include infections in immunocompromised hosts, patients with diabetes mellitus, healthcare-associated infections, antibiotic policies and studies on genetic factors predisposing to infections and their severity. He is a member of the Executive Committee of ESCMID Study Group for Antimicrobial Stewardship (ESGAP).

Declaration of Interests

Professor Kofteridis has received honoraria for lectures and conference attendance from pharmaceuticals companies including MSD, Pfizer and Angelini.

Current Positions and Research Interests

Eva Krockow is an Assistant Professor in Psychology at the University of Leicester and the Lead of the School of Psychology and Vision Sciences’ Health & Wellbeing (with Ageing) Research Group. Her research pertains to health-related decision making with a particular interest in doctor and patient choices around antibiotic treatment options as well as public health risk communication about antimicrobial resistance. Her research is underpinned by mixed-methods social science approaches (e.g. interviews and behavioural experiments) and cross-cultural studies (e.g., spanning the UK and South Africa).

Declaration of Interests

Dr Krockow has received research funding from the UK’s Economic and Social Research Council (ESRC) and the UK’s National Institute for Health and Care Research (NIHR). She also works as a blogger at Psychology Today.

@IDRoadrunner

Current Positions and Research Interests

Dr Kullar is a consultant infectious diseases pharmacist and epidemiologist focused on antimicrobial resistance (AMR). Her research and clinical interests include finding solutions to slowing the development of AMR through antimicrobial stewardship initiatives, multidisciplinary global collaboration, education to clinicians and the public and global awareness. She has also been involved in implementing stewardship initiatives in long-term care facilities/nursing homes—a healthcare setting with limited resources. Dr Kullar has published over 30 research papers and is three-time-invited TEDx speaker focused on AMR. Her passion for this work stems from personal experiences with patients in her care with infections resistant to almost every antibiotic.

Declaration of Interests

None to declare.

Current Positions and Research Interests

Paul Long is a microbiologist by training and is currently Professor of Marine Biotechnology & Therapeutics in the Institute of Pharmaceutical Science at King's College London and, International Visiting Research Professor at the Faculdade de Ciências Farmacêuticas, Universidade de São Paulo Brazil. His research uses bioinformatics, next-generation sequencing, wet laboratory and field experiments to discover marine derived natural products, creating new pharmaceuticals for human health.

Declaration of Interests

None to declare.

@NenadMacesic

Current Positions and Research Interests

Dr Macesic is an Infectious Diseases consultant physician and Clinical Infectious Diseases Genomics Service Lead at Alfred Hospital, Melbourne, Australia. Dr Macesic has extensive clinical experience in caring for patients affected by AMR, in particular immunocompromised patients such as transplant recipients. He also holds an appointment as a Senior Research Fellow and Leader of the Centre to Impact AMR at Monash University, Melbourne, Australia. Dr Macesic’s research focuses on using genomics and novel bioinformatics and artificial intelligence approaches to improve our diagnosis and treatment of MDR/XDR Gram-negative bacterial infections.

Declaration of Interests

Dr. Macesic has received research support from GlaxoSmithKline. Dr. Macesic is supported by a National Health and Medical Research Council of Australia (NHMRC) Emerging Leader 1 Fellowship (APP1176324).

Current Positions and Research Interests

Jo McEwen works in NHS Tayside where she was appointed as the UK’s first Advanced Nurse Practitioner in Antimicrobial Stewardship. Jo completed her undergraduate and postgraduate education at the University of Dundee where she currently holds a Senior Clinical Teacher role relating to embedding antimicrobial stewardship into both undergraduate and postgraduate nursing education.

She is the first and current chair of the Scottish Antimicrobial Nursing Group (SANG) which is a sub-group of the Scottish Antimicrobial Prescribing Group.

Her current areas of research interest include antimicrobial stewardship and nursing practice, influence of non-medical prescribing in antimicrobial stewardship and urinary tract infection management.

Declaration of Interests

Jo McEwen receives no industry funding or honoraria.

@domhnallnacasag

Current Positions and Research Interests

Donald Morrison is a lecturer in microbiology at Edinburgh Napier University. Prior to this he worked for over two decades as a clinical scientist/microbiologist in two UK national reference laboratories. Antibiotic-resistant pathogens (ESBL and carbapenem-resistant Enterobacteriaceae, VRE and MRSA) both in the hospital and the natural environment have formed the basis of his research activities. His recent research has focused on assessing the prevalence and distribution of AMR pathogens in environmental hotspots such as wastewater treatment plants and investigating the contribution of rivers, coastal waters and wild animals in the dissemination of these AMR pathogens from the environment to the human population.

Declaration of Interests

Donald is a member of the Advisory Committee on Animal Feedingstuffs (ACAF, Food Standards Agency) and on the FSA’s Register of Specialists. He is a Co-I on the NHS Assure Research Service Commissioning Partner. He has received research funding from academia, UK research councils, scientific societies, NHS, charities and a pharmaceutical company (Schulke & Mayr). He has also received honoraria for lectures, PhD examinations and funding application reviews from academia, government and industry. He is member of BSAC, Society for Applied Microbiology and Microbiology Society.

Current Positions and Research Interests

Dr Nix is a Professor of Pharmacy Practice & Science at the University of Arizona and a Clinical Pharmacist (Infectious Disease) and co-Director Antimicrobial Stewardship at Banner University Medical Center, Tucson. His research interests include pharmacokinetics/pharmacodynamics of antimicrobial agents and antibiotic stewardship with focus on managing bacterial resistance and antifungal drug use.

Declaration of Interests

None to declare.

Current Positions and Research Interests

Ivan Palagin is an Assistant Professor at the Urology Department of Smolensk State Medical University and Research Fellow at the Institute of Antimicrobial Chemotherapy of Smolensk State Medical University, Russia. His main research interests are urinary tract infections, epidemiology and mechanisms of antibiotic resistance of uropathogens and antimicrobial stewardship. He is the head of "DARMIS" Study Group assessing dynamic monitoring of antimicrobial resistance of uropathogens causing community-acquired urinary tract infections in different subsets of patients in Russia.

Declaration of Interests

Dr. Ivan Palagin has received honoraria for lectures, conference attendance or consultancy from both academia and a number of pharmaceutical companies.

@Nuno_R_Pereira

Current Positions and Research Interests

Dr. Rocha-Pereira works in the Unit for Infection and Antimicrobial Resistance Prevention and Control and in Infectious Diseases Department, both at Centro Hospitalar e Universitário São João, Porto, Portugal. He is also an Invited Teacher of Medicine at Faculdade de Medicina da Universidade do Porto, Portugal. Since 2018 he has had role in the national board of the Portuguese Program for Infection and Antimicrobial Resistance Prevention and Control. His main research interests are antimicrobial stewardship, antimicrobial resistance, infection prevention and control, treatment of infections caused by MDR/XDR bacteria and infections in special hosts.

Declaration of Interests

Dr. Rocha-Pereira has received funding or honoraria for lectures and conference attendance from the following pharmaceutical companies: Gilead, Janssen, ViiV Healthcare, Merck and Pfizer. He is a member of the European Study Group for Antimicrobial Stewardship (ESGAP).

@neilthepcist

Current Positions and Research Interests

Neil is a Consultant Antimicrobial Pharmacist and Associate Director of Antimicrobial Stewardship at the Royal Cornwall Hospital Trust. Neil is a current NIHR/HEE Clinical Doctoral Research Fellow looking at how to implement penicillin allergy de-labelling as part of antimicrobial stewardship programmes. Other research interests include procalcitonin as an antimicrobial stewardship tool and the role of shared decision making in optimizing antimicrobial prescribing.

Declaration of Interests

Neil has received funding or honoraria for lectures, conference attendance or consultancy from a number of companies including Pfizer, Thermo Fisher Scientific, bioMérieux and Cardiome Pharma Corp.

Current Positions and Research Interests

Dr Denasha Reddy is an infectious diseases physician from Johannesburg, South Africa. Her academic and clinical interests are broad and include public health infectious diseases, parasitology and tropical medicine, HIV-related infections and therapy, and antimicrobial resistance. Her main AMR interests relate to AMR in LMICs and the use of vaccines for AMR. She previously worked as an attending infectious diseases physician at Chris Hani Baragwanath Academic Hospital where she implemented several successful AMS interventions, and is currently a PhD fellow at Wits-VIDA investigating Klebsiella pneumoniae invasive disease in adults.

Declaration of Interests

None to declare.

Current Positions and Research Interests

Elda Righi is an Infectious Diseases physician currently working at the Department of Infection at Guy’s and St Thomas’ NHS Foundation Trust, London, UK. Dr Righi holds a PhD in Clinical and Experimental Immunology and has special interest in studying the impact of antibiotic treatments on the human microbiome. Dr Righi serves on the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Ethics Advisory Committee and is involved in research and educational activities related to infectious diseases ethics (IDE) and their applications to research and clinical guidelines. Her main interests include the study of MDR bacteria in the nosocomial setting, the management of infections in immunocompromised hosts, and the use of digital technology in the field of infectious diseases.

Declaration of Interests

None to declare.

@r_rosato

Current Positions and Research Interests

Dr Adriana Rosato is the Director of the Center for Molecular Medicine at the Maine Health Institute for Research and a visitor Professor of Medicine at Tufts University. She has a joint academic appointment at the Riverside University Health System and University of California as Professor of Infectious Diseases. Prior to that appointment she was a Faculty Scientist and Associate Professor at the Center for Molecular & Translational Human Infectious Diseases Research at the Houston Methodist Research Institute. Dr Rosato is an experienced national and international clinical and basic microbiologist/molecular biologist with special interests in the area of infectious diseases/antimicrobial development and antimicrobial resistance. Her works in infectious diseases have extended for more than 25 years covering clinical, basic and translational aspects of related diseases and their interactions with the host. She is contributing and advising the field of antimicrobial resistance by participating in revision of scientific advances and discoveries at the NIH and European Agencies, having had the opportunity to contribute her input to important decisions of funding and studies in the area of antimicrobial resistance. More importantly, over the years she has strongly committed to mentoring young investigators and served as a primary mentor for several individuals including minorities as part of her education mission. She serves on several editorial boards, has received many national and international honors and awards, and has published more than 60 research articles.

Declaration of Interests

None to declare.

Current Positions and Research Interests

Dr Joaquim Ruiz is Titular Researcher and Head of the Group of Antimicrobial Resistance Dynamics – One Health in Universidad Cientifica del Sur (Lima, Peru). His main research interests are the study of antimicrobial resistance, with a special emphasis on the dynamics of antimicrobial-resistant microorganisms and antimicrobial resistance mechanism dissemination within different environments. Additionally, he has a special interest on Carrion’s disease, an endemic Andean disease related to Bartonella bacilliformis infection.

Declaration of Interests

Research by Dr Ruiz has been mainly supported by funds from Peruvian national agencies and the World Bank. He has also received research funds or participated in projects supported by pharmaceutical companies, including Merck, Pfizer and Shionogi.

Current Positions and Research Interests

Dr Priscilla Rupali is Professor of the Department of Infectious Diseases at Christian Medical College Vellore in South India, where she runs a very popular Clinical Tropical Medicine course with an internationally acclaimed faculty. She previously worked as a Senior ID fellow in the Department of Adult Infectious Diseases at Auckland City Hospital and as a faculty member of the Fellowship in HIV Medicine, a pioneering distance learning course in the early 2000s. She trained in transplant infectious diseases at the Henry Ford Hospital in Detroit and has since helped to establish transplant-related services in her hospital, founding the Transplant Infectious Diseases Conference in Vellore, Chennai and Ludhiana.

Dr Rupali has been instrumental in setting up an antimicrobial stewardship programme in her hospital and plans to diversify to implement antimicrobial stewardship at the primary, secondary and tertiary care levels through various novel training programmes, targeting clinical pharmacists and physicians working long term at secondary care hospitals.

She holds extensive knowledge and experience in the field of enteric fever, leading a number of studies with emphasis on treatment and MDR of Salmonella.

Declaration of Interests

None to declare. 

@MSemret

Current Positions and Research Interests

Dr Semret is the Academic Lead, Antimicrobial Stewardship Program, McGill University Health Centre; Director, Training Program in Infectious Diseases, McGill University; and an Assistant Professor of Medicine, Infectious Diseases and Medical Microbiology, McGill University. Her current research focus is on assessing interventions to reduce the burden of antimicrobial resistance in high and low-resource settings. She is the Principal Investigator of a longitudinal cohort study assessing the burden of antimicrobial resistance and the impact of a laboratory-supported antimicrobial stewardship intervention in Ethiopia’s principal tertiary care hospital, and the Canadian site PI of a multinational study assessing the impact of prescription quality and antimicrobial stewardship on the gut microbiota (the PILGRIM study).

Declaration of Interests

Dr Semret has received in-kind support from bioMérieux (France) and from Antimicrobial Therapy, Inc. (Publisher of the Sanford Guide).

@DrSupram

Current Positions and Research Interests

Dr Supram specializes in clinical microbiology. He is currently an immersion fellow in clinical microbiology and infectious diseases at Weill Cornell Medicine/New York-Presbyterian Hospital. Prior to this, he was an assistant professor of microbiology at Manipal College of Medical Science, Nepal. Dr Supram’s research interests include infectious diseases and antimicrobial resistance. His main focus is on one-health genomic surveillance and understanding in depth how MDR bacteria colonize and infect humans in order to provide the best possible healthcare. Supram has published more than 50 peer-reviewed articles. He has served as an editor for several journals. Over 20 awards have been bestowed on him by international scientific societies. The American Society for Microbiology (ASM), Applied Microbiology International (AMI) and the Society for Healthcare Epidemiology of America (SHEA) appointed him as an International Young Ambassador of Science for his excellence in research and commitment to improving healthcare epidemiology and diagnostics in LMICs.

Declaration of Interests

None to declare. 

@carolynctarrant

Current Positions and Research Interests

Carolyn Tarrant is Professor of Health Services Research, in the Department of Population Health Sciences, University of Leicester. She is a social scientist with expertise in qualitative methods in healthcare research. Her primary research interests include behavioural and social influences on antibiotic use and antimicrobial stewardship in healthcare, and process evaluation of interventions to improve healthcare delivery.

Declaration of Interests

Carolyn Tarrant has received research support from the National Institute for Health and Care Research, and UK Research and Innovation.

Current Positions and Research Interests

Giusy Tiseo is an infectious diseases researcher at the University Hospital of Pisa (Italy). Her research and clinical interests include antimicrobial resistance, infections caused by MDR organisms in critically ill and immunocompromised patients, and implementation of antimicrobial stewardship strategies. She has conducted studies on carbapenem-resistant Gram-negative bacilli (CR-GNB) and has specific expertise in the management of infections by KPC- and MBL-producing Enterobacterales, and in treatment strategies of infections caused by Acinetobacter baumannii. She also led the development of guidelines about the management and treatment of infections caused by MDR organisms endorsed by five Italian Societies of Infectious Diseases. She has experience in methodology and data analysis applied to clinical research.

Declaration of Interests

Dr Tiseo has received honoraria for Educational Meetings by Shionogi.

@MariadelMarTom

Current Positions and Research Interests

M. Tomas MD is a microbiologist and leads the MicroTM research group (http://www.mariatomas.me/), which is made up of 10 people who belong to the CHUAC microbiology department as well as the Biomedical research institute, INIBIC (Institute of Biomedical Research of A Coruña). She is a researcher at the Spanish Network for Research in Infectious Diseases (REIPI), a member of the board of directors of the Spanish Society of Microbiology and Infectious Diseases (SEIMC) and a Microbiologist Spanish representative of the European Union of Specialist Doctors (UEMS). She has more than 100 publications (90 first quartile) in peer-reviewed journals indexed in Web of Science, >5.000 citations, h-index = 38, i-10-index = 62. She has been director of four defended doctoral theses (two international mentions) and currently supervises five PhD students at INIBIC-CHUAC. She has worked on 10 projects as principal investigator, of which five are research projects and five are innovation projects. She has three patents in clinical microbiology. Her main lines of research are development of innovative molecular techniques in microbiological diagnosis with patentability character; molecular mechanisms of bacterial persistence and tolerance; and phage therapy and bacterial anti-persistence treatments against MDR pathogens.

Declaration of Interests

None to declare.

Current Positions and Research Interests

Dr Tusiimire is a Senior Lecturer in the Department of Pharmacy and Deputy Dean of Faculty of Medicine at Mbarara University of Science and Technology (MUST). He is a senior researcher and founding member of the MUST Antimicrobial Stewardship (MUSTAMS) research group, patron of the MUST Students’ AMR Club, and an advisory committee member of Uganda’s National AMR Student’s Committee (NAMRSC). His group contributes towards antimicrobial stewardship and quality improvement interventions in Mbarara Regional Referral Hospital (MRRH), a teaching and research hospital based in Southwestern Uganda. Dr Tusiimire works closely with the hospital’s infectious diseases unit, AMS subcommittee, the microbiology department, and other multidisciplinary teams to coordinate AMR fight. Through this close collaboration, he has contributed to the development of local antibiograms and treatment algorithms based on the current trends of AMR in the region. He has also played key roles in developing national policies and guidelines on how to manage effective stewardship programmes based on the WHO and Africa CDC guidance. His research interests are in understanding the key drivers of AMR and creating new strategies for improved AMS in resource-limited settings through capacity building. A Jubilee Commonwealth Scholar, Dr Tusiimire holds a PhD in Pharmaceutical Analysis from the University of Strathclyde, Glasgow and a Bachelor of Pharmacy from Makerere University.

Declaration of Interests

Dr Tusiimire has previously received research funding from Pfizer.

Current Positions and Research Interests

Dr Veve is a Clinical Associate Professor of Pharmacy Practice at the Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University, and a Clinical Pharmacy Specialist in infectious diseases at Henry Ford Hospital. His research and practice focus on the implementation and assessment of novel antimicrobial stewardship interventions, the epidemiology and outcomes of MDR pathogens, antimicrobial optimization in specialized patient populations, and prevention and treatment of infections due to injection-drug use.

Declaration of Interests

Dr Veve has received funding from or acted as a consultant for the following: Merck Sharp & Dohme, bioMérieux Inc., Innoviva Specialty Therapeutics, Pfizer Inc., the Blue Cross Blue Shield of Michigan Foundation, and the American Society of Health System Pharmacists.

Current Positions and Research Interests

Prof. Vlahović-Palčevski is a Clinical Pharmacologist works at the Clinical Hospital Center Rijeka and the University of Rijeka Medical Faculty and Faculty of Health Studies. Her main interests are pharmacoepidemiology and rational drug use with a focus on antimicrobials. She has been involved in various antimicrobial stewardship activities on the local, national and international level (designing and conducting antibiotic campaigns, monitoring antibiotic consumption, developing guidelines and policies for antimicrobial drug use, teaching on all levels). Her main research interests are antimicrobial stewardship and antimicrobial consumption.

Declaration of Interests

Prof. Vlahović-Palčevski has received research funding, unrestricted grants or honoraria for lectures or consultancy from academia, IMI, ECDC, WHO and pharmaceutical companies.

Current Positions and Research Interests

Andrew Whitelaw is the head of the Division of Medical Microbiology at Stellenbosch University Faculty of Medicine and Health Sciences, and National Health Laboratory Service, Tygerberg Hospital, Cape Town, South Africa. He is actively involved in AMS and IPC programmes at a local and national level. His research interests include mechanisms of antibiotic resistance, clinical impact of AMR, neonatal sepsis and infection control, and epidemiology and virulence of staphylococcal infections.

Declaration of Interests

Andrew has received honoraria/consulting fees from MSD, Takeda, Novartis and Astra Zeneca, and travel support from MSD and Becton Dickinson.

@CWoodsHillMD

Current Position and Research Interests

Dr Woods-Hill MD MSHP is an Assistant Professor of paediatrics and paediatric critical care at the University of Pennsylvania Perelman School of Medicine and Children’s Hospital of Philadelphia, as well as a Senior Fellow at the Leonard Davis Institute of Health Economics at the University of Pennsylvania. She has formal training in health policy, qualitative research and implementation science from the University of Pennsylvania. Her research interests include the intersection of healthcare resource utilization, diagnostic/antimicrobial stewardship, implementation science, and qualitative research as it relates to preventable paediatric patient harm and paediatric patient safety. 

Declaration of Interests

Dr Woods-Hill receives funding from the National Institute of Health under award K23HL151381 and from the Agency for Healthcare Research and Quality under award 1R18HS025642. She has no conflicts of interest to declare.

@wwrighID

Current Positions and Research Interests

Dr Wright is an Assistant Professor of Medicine and Infectious Diseases at Johns Hopkins University School of Medicine. He is the Clinical Director of the Infectious Diseases Inpatient and Outpatient Program at Johns Hopkins Bayview Medical Center. He is also a Member of the Infectious Diseases Society of America (IDSA). He is the creator of #AMRrounds with interests in the epidemiology of antimicrobial resistant mechanisms as well as improving patient outcomes through antimicrobial stewardship. His primary clinical research interests include the epidemiology and evaluation of prolonged undiagnosed febrile conditions known as fever of undetermined or unknown origin (FUO).

Declaration of Interests

Research by Dr Wright is mainly supported by funding agencies of Johns Hopkins University.

@zarbp002

Current Positions and Research Interests

Dr Peter Zarb is the Antibiotic (& ICU) Pharmacist, within the Infection Prevention and Control Department, at the only Tertiary care hospital in Malta, Mater Dei Hospital. At hospital he is part of the Antimicrobial Management Team. Peter is also a visiting Senior Lecturer at the University of Malta, lecturing mainly future pharmacists and doctors. He is also the secretary for the Maltese National Antibiotic Committee (NAC) (www.nac.gov.mt) which is the official body responsible for monitoring Antimicrobial Consumption (AMC) in Malta.

On behalf of the NAC he submits Maltese data to the  (European Centre for Disease Prevention and Control) ECDC’s antimicrobial consumption network (ESAC-Net). He was part of the ESAC Management Team, ESAC-Net’s predecessor and is currently the chair for ESAC-Net disease network coordination committee (DNCC).

His research interests include the prospect of ensuring all countries, especially lower and middle income countries develop simple but sturdy antimicrobial consumption surveillance systems with the aim of identifying targets for quality improvement in antimicrobial use. Such surveillance systems could include either general consumption data at National and/or hospital level, as well as, point-prevalence-surveys (PPS) in hospitals.

Declarations of Interests

Dr Zarb has acted as facilitator/consultant for the World Health Organization on AMC and PPS methodologies. He also was part of the Team that developed the Global-PPS on antimicrobial use (http://www.global-pps.com/).